-
Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021
-
View Affiliations Hide AffiliationsRichard Molenkampr.molenkamp erasmusmc.nl
-
View Citation Hide Citation
Citation style for this article: . Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021. Euro Surveill. 2021;26(40):pii=2100921. https://doi.org/10.2807/1560-7917.ES.2021.26.40.2100921 Received: 21 Sept 2021; Accepted: 06 Oct 2021
- Previous Article
- Table of Contents
- Next Article
Abstract
We evaluated routine testing with SARS-CoV-2 Delta variant-specific RT-PCR in regional hospital laboratories in addition to centralised national genomic surveillance in the Netherlands during June and July 2021. The increase of the Delta variant detected by RT-PCR correlated well with data from genomic surveillance and was available ca 2 weeks earlier. This rapid identification of the relative abundance and increase of SARS-CoV-2 variants of concern may have important benefits for implementation of local public health measures.
Full text loading...